Jasmin Velic, 43, speaks to lab technician Sasha Gaye Phillips as she prepares to draw his blood before his weekly chemotherapy session at Toronto's Princess Margaret Cancer Centre in Oct., 2025.EDUARDO LIMA/The Globe and Mail
Listen to this episode by clicking above or subscribe to The Decibel on your favourite podcast app or platform: Apple Podcasts, Spotify, Amazon Music, iHeartRadio, Pocket Casts and YouTube.
For cancer patients, every day of treatment is critical. But the best care possible is not always reaching patients quickly. Despite Health Canada approving a drug treating an aggressive blood cancer, a complex web of organizations, insurance plans and negotiations over drug pricing means it’s still not available in Canada.
Globe reporters Kelly Grant, who covers health, and Chris Hannay, who covers the business of health care, tell us what is holding up life-changing drugs and why Canadian patients are the ones left with the consequences.
Questions? Comments? Ideas? E-mail us at thedecibel@globeandmail.com